| |
| |
|
| Insider
Information: |
Kelly John Alexander |
| Relationship: |
|
| City: |
New York |
| State: |
NY |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
31,014 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$356,661 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
31,014 |
|
|
| Total
Value |
$356,661 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
5
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
5
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
-5.0
|
0.0
|
| Percentage
Gain/Loss : |
 -50.5%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Precision Biosciences Inc |
DTIL |
|
2024-05-08 |
31,014 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
19 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| DTIL |
Precision Biosciences Inc |
Chief Financial Officer |
• – – |
2024-05-08 |
4 |
A |
$12.00 |
$100,008 |
D/D |
8,334 |
31,014 |
0 |
- |
|
| DTIL |
Precision Biosciences Inc |
Chief Financial Officer |
• – – |
2024-05-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,702 |
22,680 |
0 |
- |
|
| DTIL |
Precision Biosciences Inc |
Chief Financial Officer |
• – – |
2024-02-29 |
4 |
A |
$18.50 |
$9,361 |
D/D |
506 |
20,978 |
0 |
- |
|
| DTIL |
Precision Biosciences Inc |
Chief Financial Officer |
• – – |
2024-01-20 |
4 |
OE |
$0.00 |
$0 |
D/D |
116,690 |
614,169 |
0 |
- |
|
| DTIL |
Precision Biosciences Inc |
Chief Financial Officer |
• – – |
2023-11-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
108,188 |
497,479 |
0 |
- |
|
| DTIL |
Precision Biosciences Inc |
Chief Financial Officer |
• – – |
2023-08-31 |
4 |
A |
$0.39 |
$2,321 |
D/D |
5,951 |
389,291 |
0 |
- |
|
| DTIL |
Precision Biosciences Inc |
Chief Financial Officer |
• – – |
2023-08-18 |
4 |
A |
$0.48 |
$43,200 |
D/D |
90,000 |
383,340 |
0 |
- |
|
| DTIL |
Precision Biosciences Inc |
Chief Financial Officer |
• – – |
2023-08-18 |
4/A |
B |
$0.48 |
$43,200 |
D/D |
90,000 |
383,340 |
2.74 |
- |
|
| DTIL |
Precision Biosciences Inc |
Chief Financial Officer |
• – – |
2023-06-07 |
4 |
OE |
$0.00 |
$0 |
D/D |
47,726 |
293,340 |
0 |
- |
|
| DTIL |
Precision Biosciences Inc |
Chief Financial Officer |
• – – |
2023-03-17 |
4 |
B |
$0.86 |
$17,200 |
D/D |
20,000 |
245,614 |
2.74 |
% |
|
| DTIL |
Precision Biosciences Inc |
Chief Financial Officer |
• – – |
2023-03-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
51,071 |
225,614 |
0 |
- |
|
| DTIL |
Precision Biosciences Inc |
Chief Financial Officer |
• – – |
2023-02-28 |
4 |
A |
$0.95 |
$11,025 |
D/D |
11,605 |
174,543 |
0 |
- |
|
| DTIL |
Precision Biosciences Inc |
Chief Financial Officer |
• – – |
2022-09-23 |
4 |
B |
$1.23 |
$10,086 |
D/D |
8,200 |
162,938 |
2.74 |
% |
|
| DTIL |
Precision Biosciences Inc |
Chief Financial Officer |
• – – |
2022-09-22 |
4 |
B |
$1.34 |
$49,630 |
D/D |
37,037 |
154,738 |
2.74 |
% |
|
| DTIL |
Precision Biosciences Inc |
Chief Financial Officer |
• – – |
2022-06-22 |
4 |
B |
$1.50 |
$50,676 |
D/D |
33,784 |
117,701 |
2.74 |
% |
|
| DTIL |
Precision Biosciences Inc |
Chief Financial Officer |
• – – |
2022-03-17 |
4 |
B |
$3.08 |
$51,365 |
D/D |
16,677 |
36,189 |
2.74 |
% |
|
| DTIL |
Precision Biosciences Inc |
Chief Financial Officer |
• – – |
2022-02-28 |
4 |
A |
$3.61 |
$9,798 |
D/D |
2,714 |
19,512 |
0 |
- |
|
| DTIL |
Precision Biosciences Inc |
Chief Financial Officer |
• – – |
2021-08-31 |
4 |
A |
$10.68 |
$10,659 |
D/D |
998 |
16,798 |
0 |
- |
|
| DTIL |
Precision Biosciences Inc |
Interim CFOOfficer |
• – – |
2021-01-01 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
15,800 |
|
% |
|
19 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
